Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 0.95 |
| ▸ | ACHE | P22303 | 8/20 | 0.59 |
| ▸ | CASP2 | P42575 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10118264 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 | |
| SCHEMBL28556990 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 | |
| SCHEMBL717504 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 | |
| SCHEMBL28335637 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 | |
| SCHEMBL13387440 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 | |
| SCHEMBL13387508 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 | |
| SCHEMBL3910901 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 | |
| SCHEMBL1616893 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 | |
| SCHEMBL22693961 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 | |
| SCHEMBL27052567 | 0.98 | EPHX1 (1.00) | EPHX1ACHECASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7687490-B2 | 2-thioethenyl substituted carbapenem derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 2010-03-30 | — | — | US | claimed |
| EP-1870412-A1 | 2-THIOETHENYL CARBAPENEM DERIVATIVE | MEIJI SEIKA KAISHA LTD. (JP) | 2007-12-26 | — | — | EP | claimed |
| US-20070004700-A1 | 2-Thioethenyl substituted carbapenem derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 2007-01-04 | — | — | US | claimed |
| EP-0521827-B1 | Pharmacological active hydrazin derivatives and process for their preparation | CIBA GEIGY AG (CH) | 1996-09-25 | — | — | EP | claimed |
| EP-0241735-A2 | Acyloxythiophene carbon amide | BAYER AG (DE) | 1987-10-21 | — | — | EP | claimed |
| EP-4325622-A1 | SECONDARY BATTERY ELECTROLYTE SOLUTION AND SECONDARY BATTERY | Murata Manufacturing Co., Ltd. (JP) | 2024-02-21 | — | — | EP | disclosed |
| US-20230174483-A1 | INDIRUBIN DERIVATIVES, AND USES THEREOF | CITY OF HOPE (US) | 2023-06-08 | — | — | US | disclosed |
| US-20230174483-A1 | INDIRUBIN DERIVATIVES, AND USES THEREOF | CITY OF HOPE (US) | 2023-06-08 | — | — | US | disclosed |
| US-11524937-B2 | Indirubin derivatives, and uses thereof | CITY OF HOPE (US) | 2022-12-13 | — | — | US | disclosed |
| WO-2022255018-A1 | SECONDARY BATTERY ELECTROLYTE SOLUTION AND SECONDARY BATTERY | 株式会社村田製作所 | 2022-12-08 | — | — | WO | disclosed |
| CN-109641835-B | Method for producing carbamate | 国立研究开发法人产业技术综合研究所 | 2021-07-20 | — | — | CN | disclosed |
| EP-3508473-B1 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | AIST (JP) | 2021-05-26 | — | — | EP | disclosed |
| EP-0420520-A1 | Pesticidal compositions | ROUSSEL-UCLAF (FR) | 1991-04-03 | — | — | EP | disclosed |
| EP-0119954-B1 | 3-AMINO-1-BENZAZEPIN-2-ONE-1-ALCANOIC ACIDS, PROCESS FOR THEIR PREPARATION, THEIR PHARMACEUTICAL PREPARATION AS WELL AS THEIR THERAPEUTIC USE | CIBA-GEIGY AG (CH) | 1990-03-14 | — | — | EP | disclosed |
| EP-0119161-B1 | BENZAZOCINONE AND BENZAZONINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS, AND THEIR THERAPEUTICAL USE | CIBA-GEIGY AG (CH) | 1989-06-28 | — | — | EP | disclosed |
| EP-0241735-A2 | Acyloxythiophene carbon amide | BAYER AG (DE) | 1987-10-21 | — | — | EP | disclosed |
| US-4477464-A | Hetero-benzazepine derivatives and their pharmaceutical use | CIBA-GEIGY CORPORATION (US) | 1984-10-16 | — | — | US | disclosed |
| EP-0119954-A2 | 3-Amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use | CIBA-GEIGY AG (CH) | 1984-09-26 | — | — | EP | disclosed |
| EP-0119161-A2 | Benzazocinone and benzazoninone derivatives, process for their preparation, pharmaceutical preparations containing these compounds, and their therapeutical use | CIBA-GEIGY AG (CH) | 1984-09-19 | — | — | EP | disclosed |
| US-4386033-A | BOILING, CONDENSATION OF VAPORS, CIRCULATION; SEPARATION | BAYER AKTIENGESELLSCHAFT (DE) | 1983-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174483-A1 | INDIRUBIN DERIVATIVES, AND USES THEREOF | HCCS, ABL1, MAP3K7 | EPHX1 3329/4885ACHE 4073/4885CASP2 2364/4885 |
| US-11524937-B2 | Indirubin derivatives, and uses thereof | HCCS, ABL1, MAP3K7 | EPHX1 3329/4885ACHE 4073/4885CASP2 2364/4885 |
| US-20070004700-A1 | 2-Thioethenyl substituted carbapenem derivatives | MTAP, BLVRB, BPGM | EPHX1 3352/4885ACHE 2739/4885CASP2 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.